MTPConnect – the Medical Technologies and Pharmaceuticals Industry Growth Centre – announced it will provide a proposed $780,000 provisional funding for CCRM Australia over two years, with matched funding coming from the sector.
The funding will allow CCRM Australia to implement the first two years of the documented proposed 5 Year Strategy designed to accelerate the commercialisation of Australian regenerative medicine technologies opening up a global network of expertise, funding and investors for Australian regenerative medicine technologies in development.
Many of Australia’s leading researchers, industry, service providers and advocates have come together in the largest national regenerative medicine industry-led consortium to date to support the creation of CCRM Australia and accelerate commercialisation of regenerative technologies.
Initially recognised as a high value opportunity for Australian regenerative medicine by CSIRO and Monash University, the project is being led by The Australian Regenerative Medicine Institute and includes Founding Members: CSIRO, Monash University and CCRM (Canada),St Vincent’s Institute for Medical Research and Cell Therapies P/L, Affiliate members include: Australian National NanoFabrication Facility, Bioplatforms Australia and the Centre for Cell Therapy Manufacturing. CCRM Australia also has a number of Partners that come from industry, government agencies and department, academia and peak bodies.
CCRM Australia is a not for profit established to address bottlenecks in the translation and commercialisation of RM discoveries in Australia.
Sue MacLeman, CEO of MTPConnect, said, “MTPConnect is focused on harnessing Australia’s world-class research to seize more commercialisation opportunities and accelerate growth. As part of our mission, we are funding big, bold ideas that will deliver results on a national scale, have sector-wide impact, and are aligned with the Sector Growth Priorities we have identified in our 10-year Sector Competitiveness Plan. By supporting project such as CCRM Australia, we believe we can develop a more vibrant MTP sector ecosystem with more successful companies, and ultimately improve the health and wellbeing of Australia and the world.”
“CCRM Australia is the first in a global network of regenerative medicine hubs in development, associated with CCRM Canada, said Mr Silvio Tiziani, Executive Director of CCRM Australia. The CCRM opportunity was initially recognised by CSIRO and Monash University “The link between Australian regenerative technology researchers and counterparts in Canada has been one that has been in place for some years, but with this funding support and the engagement from so many industry stakeholders in this Australian initiative, we are confident that this accelerated approach to translation will yield far more impactful returns and stronger clinical benefits, sooner.”